<p>Mutations in adult hemoglobin alpha genes in humans lead to blood disorders commonly known as α-thalassemia. In search of a mouse model for this disease, mutagenesis screens have identified several deletions that resemble these phenotypes. The <i>Hba</i><sup><i>b2(th)</i></sup> deletion, in particular, replicates the characteristics of alpha-thalassemia minor in heterozygous mice but presents a homozygous embryonic lethal phenotype. Previous analyses of <i>Hba</i><sup><i>b2(th)</i></sup> mice suggested that the deletion affects both <i>Hba</i> genes (<i>Hba-a1</i> and <i>Hba-a2</i>) and considered epidermal growth factor receptor (<i>Egfr</i>) or rhomboid 5 homolog 1 (<i>Rhbdf1</i>) to be responsible for the embryonic lethality. Molecular analysis of <i>Hba</i><sup><i>b2(th)</i></sup> revealed a deletion spanning a 1&#xa0;cM region of mouse chromosome 11. Importantly, the <i>Hba</i><sup><i>b2(th)</i></sup> deletion does not extend to <i>Egfr</i>, indicating that the observed lethality of homozygous embryos is not due to the loss of <i>Egfr</i>. Sequence analysis of the <i>Hba</i><sup><i>b2(th)</i></sup> deletion showed that the <i>Hba-a2</i> gene is not deleted, but the lack of expression is likely due to the disruption of upstream regulatory regions. Furthermore, we identify <i>Snrnp2</i>5, which codes for the small nuclear ribonucleoprotein 25 (U11/U12), as the candidate gene most likely responsible for the peri-implantation lethality of <i>Hba</i><sup><i>b2(th)</i></sup> homozygous mice. These findings enhance the understanding of the genetic mechanisms underlying α-thalassemia and provide insights into novel genes essential for early mammalian development.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Snrnp25 is a candidate for the peri-implantation lethal phenotype of the Hba deletions

  • Ana María Velásquez-Escobar,
  • Andrew E. Hillhouse,
  • Terry Magnuson,
  • David W. Threadgill

摘要

Mutations in adult hemoglobin alpha genes in humans lead to blood disorders commonly known as α-thalassemia. In search of a mouse model for this disease, mutagenesis screens have identified several deletions that resemble these phenotypes. The Hbab2(th) deletion, in particular, replicates the characteristics of alpha-thalassemia minor in heterozygous mice but presents a homozygous embryonic lethal phenotype. Previous analyses of Hbab2(th) mice suggested that the deletion affects both Hba genes (Hba-a1 and Hba-a2) and considered epidermal growth factor receptor (Egfr) or rhomboid 5 homolog 1 (Rhbdf1) to be responsible for the embryonic lethality. Molecular analysis of Hbab2(th) revealed a deletion spanning a 1 cM region of mouse chromosome 11. Importantly, the Hbab2(th) deletion does not extend to Egfr, indicating that the observed lethality of homozygous embryos is not due to the loss of Egfr. Sequence analysis of the Hbab2(th) deletion showed that the Hba-a2 gene is not deleted, but the lack of expression is likely due to the disruption of upstream regulatory regions. Furthermore, we identify Snrnp25, which codes for the small nuclear ribonucleoprotein 25 (U11/U12), as the candidate gene most likely responsible for the peri-implantation lethality of Hbab2(th) homozygous mice. These findings enhance the understanding of the genetic mechanisms underlying α-thalassemia and provide insights into novel genes essential for early mammalian development.